miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype
Authors:
- 19 April 2013
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 114 (10) , 2248-2257
Abstract
Resistance to chemotherapy is a major obstacle for the effective treatment of breast cancer and is partially due to the presence of drug resistant stem cell‐like side population (SP). Previous studies have shown elevated miR‐125b is associated with chemoresistance and metastasis; however, the relationship between miR‐125b and SP cells remains unknown. In this study, we isolated and characterized SP cells in a panel of breast cancer cell lines and primary cancer cells from breast cancer patients. SP cells showed cancer stem cells (CSCs) properties, including self‐renewal, resistance to chemotherapy and high expression of stem cell markers. The percentage of SP cells was higher in chemotherapy resistant patients compared to that in chemotherapy responsive patients (5.8 ± 2.4% in non‐responsive patients vs. 1.2 ± 0.5% in responsive patients, P = 0.012). Importantly, SP cells had higher level of miR‐125b than NSP cells and the elevated miR‐125b expression in chemoresistant cancer cells were due to high percentage of SP cells. Overexpression of miR‐125b correlated with an increase in tumor SP and CSC property, whereas knockdown of miR‐125b correlated with decreased incidence of SP. In addition, miR‐125b overexpression in breast cancer cells induced epithelial–mesenchymal transition (EMT)‐like cellular marker alteration, suggesting a potential mechanism of miR‐125b in the regulation of cancer stem‐like SP cells. Taken together, these results suggest an important role for miR‐125b in breast cancer chemoresistance by maintaining cancer stem‐like SP fraction, and raise the possibility that miR‐125b may be a significant prognostic response marker for cancer therapy. J. Cell. Biochem. 114: 2248–2257, 2013.Keywords
This publication has 39 references indexed in Scilit:
- Breast cancer, side population cells and ABCG2 expressionCancer Letters, 2012
- MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypesBreast Cancer Research and Treatment, 2011
- Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell CharacteristicsJNCI: Journal of the National Cancer Institute, 2010
- Hypoxia Increases the Expression of Stem-Cell Markers and Promotes Clonogenicity in Glioblastoma NeurospheresThe American Journal of Pathology, 2010
- Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: Towards targeting of cancer stem cells with phytochemicalsCancer Letters, 2010
- ABC Transporters, Drug Resistance, and Cancer Stem CellsJournal of Mammary Gland Biology and Neoplasia, 2009
- MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic PancreatitisJAMA, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Clonogenic assay with established human tumour xenograftsEuropean Journal of Cancer, 2004
- PEBA Regimen (Cisplatin, Etoposide, Bleomycin, and Adriamycin) in the Treatment of Drug-Resistant ChoriocarcinomaGynecologic Oncology, 1995